Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue (Q40693029)

From Wikidata
Jump to navigation Jump to search
scientific article published on 18 March 2010
edit
Language Label Description Also known as
English
Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue
scientific article published on 18 March 2010

    Statements

    Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue (English)
    1 reference
    Vanessa P Houde
    1 reference
    Sophie Brûlé
    1 reference
    Pierre-Gilles Blanchard
    1 reference
    Kerstin Bellmann
    1 reference
    Yves Deshaies
    1 reference
    André Marette
    1 reference
    18 March 2010
    1 reference
    59
    1 reference
    1338-1348
    1 reference
    6
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit